ISPC iSpecimen Inc.
USHealthcareAs of 2026-07-09 14:40
Why ISPC matters now
iSpecimen Inc. (ISPC) is a US stock in Healthcare. The latest InvestLog snapshot shows $2.54 with +10.92% on the session and $352.7K in market capitalization; recent performance reads 1-month -29.43% and YTD -75.10%.
The latest financial table shown here is Q1 2026, with revenue of $156.0K, net income of $-2.3M, and EPS of $-266.40. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -2087.3%.
The latest indexable market news headline is "E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement" from Globe News Wire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $—. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
0.01
P/S
0.35
EV/EBITDA
0.23
DCF Value
$-48.26
FCF Yield
-2087.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
-29.6%
Operating Margin
-961.4%
Net Margin
-1080.7%
ROE
-584.7%
ROA
-168.0%
ROIC
-924.0%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $156.0K | $-2.3M | $-266.40 |
| Q4 2025 | $51.8K | $-5.0M | $-23.60 |
| FY 2025 | $1.9M | $-10.5M | $-91.20 |
| Q3 2025 | $106.6K | $-2.8M | $-19.20 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
US
Exchange
—
Beta
1.62
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.